Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 90Breast Neoplasms 87Carcinoma, Non-Small-Cell Lung 33Triple Negative Breast Neoplasms 22Squamous Cell Carcinoma of Head and Neck 19Neoplasms 18Neoplasm Metastasis 18Ovarian Neoplasms 17Stomach Neoplasms 15Lung Neoplasms 13Head and Neck Neoplasms 11Esophageal Squamous Cell Carcinoma 10Esophageal Neoplasms 10Cholangiocarcinoma 10Recurrence 9Melanoma 8Small Cell Lung Carcinoma 7Sarcoma 7Pancreatic Adenocarcinoma 7Inflammatory Breast Neoplasms 7Breast Neoplasms, Male 7Adenocarcinoma 7Prostatic Neoplasms 6Fallopian Tube Neoplasms 6Urinary Bladder Neoplasms 5Carcinoma, Ovarian Epithelial 5Biliary Tract Neoplasms 5Uterine Cervical Neoplasms 4Gallbladder Neoplasms 4Carcinoma, Ductal, Breast 4

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 5pimonidazole 4fluoroazomycin arabinoside 4Radiotherapy 4Injections 3Propofol 2Positron Emission Tomography Computed Tomography 2Drug Therapy 2Blood Specimen Collection 2pembrolizumab 1inositol trispyrophosphate 1gadobutrol 1fludarabine 1alovudine 1Thoracotomy 1Thoracic Surgery, Video-Assisted 1Temozolomide 1Surgical Procedures, Operative 1Sodium Chloride 1Saline Solution 1Pancreaticoduodenectomy 1Paclitaxel 1Oxygen 1Nitroglycerin 1NVP-BKM120 1Metformin 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Letrozole 1Hydroxychloroquine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hypoxia × Albumin-Bound Paclitaxel × Clear all
NCT06939270 2025-04-22

CD73/AXL Targeted HypoSti.CAR-T Cells in CD73/AXL Positive Advanced/Metastatic Solid Tumors

Chinese PLA General Hospital

Phase 1/2 Not yet recruiting
30 enrolled

Hypoxia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡